News
-
BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent
-
Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, Strengthening Technical Acumen in AI-Powered Precision Oncology
-
Cerrado Gold Announces First Quarter Financial Results Release Date and Conference Call
-
D. Boral Capital acted as Exclusive Placement Agent to Luminar Technologies (NASDAQ:LAZR) in connection with its up to $200.0 Million Equity Linked Securities Offering
-
Kingstone Successfully Sponsors Inaugural $125 Million Catastrophe Bond
-
Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time
-
The Platform Group AG: Q1 figures with significant increase in GMV, sales and profit
-
Original-Research: NFON AG (von NuWays AG): BUY
-
Brödernas Group AB (publ) delays the publication of the annual audited consolidated financial statements of the Group due in April 2025
-
Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026
-
KLARSEN : Initiation de couverture de la valeur par CHAMPEIL SA
-
Vif succès de l’augmentation de capital de NFL Biosciences avec une levée plafonnée à 3 millions d’euros
-
NFL Biosciences announces the success of its capital increase capped at €3 million
-
ICADE – CP – SUCCÈS DE L’OFFRE DE RACHAT OBLIGATAIRE POUR UN MONTANT DE 265 M€
-
ICADE – PR – SUCCESS OF THE CASH TENDER OFFER FOR A TOTAL AMOUNT OF €265 MILLION